96 related articles for article (PubMed ID: 24008762)
1. SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.
Tan MY; Mu XY; Liu B; Wang Y; Bao ED; Qiu JX; Fan Y
Cell Physiol Biochem; 2013; 32(3):542-8. PubMed ID: 24008762
[TBL] [Abstract][Full Text] [Related]
2. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
[TBL] [Abstract][Full Text] [Related]
3. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
4. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
6. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
[TBL] [Abstract][Full Text] [Related]
7. SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of β-catenin.
Shen HJ; Zhu HY; Yang C; Ji F
Asian Pac J Cancer Prev; 2012; 13(8):3583-7. PubMed ID: 23098437
[TBL] [Abstract][Full Text] [Related]
8. The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.
Lu H; Liu B; Zhang FJ; Zhang J; Dong R; Chen L; Qu DM; Lu Y; Yu BW
Cell Cycle; 2014; 13(24):3892-902. PubMed ID: 25483061
[TBL] [Abstract][Full Text] [Related]
9. SENP2 exerts an anti‑tumor effect on chronic lymphocytic leukemia cells through the inhibition of the Notch and NF‑κB signaling pathways.
Chen XL; Wang SF; Liang XT; Liang HX; Wang TT; Wu SQ; Qiu ZJ; Zhan R; Xu ZS
Int J Oncol; 2019 Feb; 54(2):455-466. PubMed ID: 30431078
[TBL] [Abstract][Full Text] [Related]
10. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
Wang H; You G
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
[TBL] [Abstract][Full Text] [Related]
11. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
12. SENP2 suppresses NF-κB activation and sensitizes breast cancer cells to doxorubicin.
Gao X; Wu Y; Qiao L; Feng X
Eur J Pharmacol; 2019 Jul; 854():179-186. PubMed ID: 30940449
[TBL] [Abstract][Full Text] [Related]
13. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
[TBL] [Abstract][Full Text] [Related]
14. The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).
Xiong Y; Wang L; Li Y; Chen M; He W; Qi L
Cell Physiol Biochem; 2017; 43(1):405-418. PubMed ID: 28869948
[TBL] [Abstract][Full Text] [Related]
15. Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells.
Xu ST; Guo C; Ding X; Fan WJ; Zhang FH; Xu WL; Ma YC
Mol Med Rep; 2015 May; 11(5):3701-7. PubMed ID: 25591934
[TBL] [Abstract][Full Text] [Related]
16. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
17. Role of SUMO-specific protease 2 in reprogramming cellular glucose metabolism.
Tang S; Huang G; Tong X; Xu L; Cai R; Li J; Zhou X; Song S; Huang C; Cheng J
PLoS One; 2013; 8(5):e63965. PubMed ID: 23691130
[TBL] [Abstract][Full Text] [Related]
18. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
19. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
[TBL] [Abstract][Full Text] [Related]
20. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.
Yan L; Yan K; Kun W; Xu L; Ma Q; Tang Y; Jiao W; Gu G; Fan Y; Xu Z
Tumour Biol; 2013 Feb; 34(1):215-21. PubMed ID: 23065570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
